The Broad Institute, Verily Life Sciences, and Microsoft on Monday announced a strategic partnership to extend the Terra bioinformatics analysis platform to the Microsoft Azure cloud.
The cloud-based Terra platform was codeveloped by the Broad and Google sibling Verily Life Sciences. By offering it on Azure, the three companies hope that they can improve collaboration among many of the 168,000 data scientists, biomedical researchers, and clinicians who use Terra.
“This partnership combines multimodal data, secure analytics, and scalable cloud computing to improve insight and evidence generation, allowing us to ultimately impact more patients’ lives,” Verily COO Stephen Gillett said in a statement.
“Both Microsoft and Verily share our vision for Terra as an open and collaborative ecosystem for the sharing and analysis of biomedical data,” added the Broad’s Clare Bernard, who manages the Terra platform. “This partnership will allow us to make Terra even more useful and accessible across a broader set of researchers and industries.”
Gregory Moore, corporate VP of Microsoft Health Next, said that this arrangement will allow the tech giant to bring the security, privacy, scalability, and analytics capabilities of Azure to bioinformatics researchers worldwide.
This story first appeared in our sister publication, Genomeweb.